HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced liver cancer: experimental drug targets tumors after other therapies fail
Disease control Recruiting nowThis study tests a new drug called Becotatug vedotin (MRG003) in people with advanced liver cancer that has gotten worse after at least one prior treatment. The goal is to see if the drug can shrink tumors. About 40 adults with confirmed liver cancer will take part. The drug is g…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New drug cocktail shows promise for advanced liver cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy to a two-drug combination (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly assign…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New blood test hopes to catch liver cancer before It's too late
Diagnosis Recruiting nowThis study is testing a new blood test called Delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 200 people—half with liver cancer and half with liver cirrhosis but no cancer. The goal is to…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC